202 related articles for article (PubMed ID: 6358053)
21. Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
Rowe DJ; Beverley PC
Br J Cancer; 1984 Feb; 49(2):149-59. PubMed ID: 6365132
[TBL] [Abstract][Full Text] [Related]
22. Immunophenotypic markers in renal cell carcinoma.
Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
[TBL] [Abstract][Full Text] [Related]
23. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
24. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
[TBL] [Abstract][Full Text] [Related]
25. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
27. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
28. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
[TBL] [Abstract][Full Text] [Related]
29. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis.
Colucci G; Schaffner F; Paronetto F
Clin Immunol Immunopathol; 1986 Oct; 41(1):35-42. PubMed ID: 3488860
[TBL] [Abstract][Full Text] [Related]
30. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer.
Tagliabue E; Mènard S; Della Torre G; Barbanti P; Mariani-Costantini R; Porro G; Colnaghi MI
Cancer Res; 1985 Jan; 45(1):379-85. PubMed ID: 3965146
[TBL] [Abstract][Full Text] [Related]
31. Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions.
Magyarosy E; Martin WJ; Chu EW; Martin SE
Pathol Oncol Res; 1999; 5(1):32-5. PubMed ID: 10079375
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors.
Bodey B; Bodey B; Siegel SE
Mod Pathol; 1995 Apr; 8(3):333-8. PubMed ID: 7617661
[TBL] [Abstract][Full Text] [Related]
33. The distribution of HLA antigens on human corneal tissue.
Whitsett CF; Stulting RD
Invest Ophthalmol Vis Sci; 1984 May; 25(5):519-24. PubMed ID: 6370904
[TBL] [Abstract][Full Text] [Related]
34. A study of the Ca antigen in epithelial tumours of the ovary.
Ferguson AM; Fox H
J Clin Pathol; 1984 Jan; 37(1):6-9. PubMed ID: 6368598
[TBL] [Abstract][Full Text] [Related]
35. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
Aichinger G; Fill H; Wick G
Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
[TBL] [Abstract][Full Text] [Related]
36. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
[TBL] [Abstract][Full Text] [Related]
37. Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas.
Mettler L; Radzun HJ; Salmassi A; Köchling W; Parwaresch MR
Cancer; 1990 Apr; 65(7):1525-32. PubMed ID: 2178766
[TBL] [Abstract][Full Text] [Related]
38. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
39. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas.
Mariani-Costantini R; Agresti R; Colnaghi MI; Ménard S; Andreola S; Rilke F
Pathol Res Pract; 1985 Aug; 180(2):169-80. PubMed ID: 3903701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
